AUPH icon

Aurinia Pharmaceuticals
AUPH

Overview Fund Activity

165 hedge funds and large institutions have $637M invested in Aurinia Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 60 increasing their positions, 40 reducing their positions, and 32 closing their positions.

Holders
165
Holders Change
-2
Holders Change %
-1.2%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
30
Increased
60
Reduced
40
Closed
32
Calls
$34M
Puts
$42.5M
Net Calls
-$8.46M
Net Calls Change
-$965K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$46.9M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$31.3M
3
AS
3
Altshuler Shaham
Israel
$7.25M
4
Jane Street
4
Jane Street
New York
$3.63M
5
SGA
5
Sector Gamma AS
Norway
$3.05M

Top Sellers

1
APM
1
Avidity Partners Management
Texas
$0
2
PAMU
2
Pictet Asset Management (UK)
United Kingdom
$28.1M
3
HM
3
HealthCor Management
New York
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$110M
5
Citadel Advisors
5
Citadel Advisors
Florida
$9.14M
Name Market Value Shares Shares
Change 		Shares
Change %
IC
201
Ikarian Capital
Texas
– – – –
IA
202
IFP Advisors
Florida
– – – –
BCM
203
Bluefin Capital Management
New York
– – – –
5 6 7 8
9